# Assessment of Compliance With Antihypertensive Telmisartan Therapy

> **NCT00470886** · — · COMPLETED · sponsor: **Bayer** · enrollment: 3400 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Telmisartan (Kinzal/Pritor, BAY68-9291)

## Key facts

- **NCT ID:** NCT00470886
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 3400 (ACTUAL)
- **Last updated:** 2012-11-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00470886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00470886, "Assessment of Compliance With Antihypertensive Telmisartan Therapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00470886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*